Nuclear receptors regulate gene expression in response to environmental cues, but the molecular events governing the cell type specificity of nuclear receptors remain poorly understood. Here we outline a role for a long noncoding RNA (lncRNA) in modulating the cell type-specific actions of liver X receptors (LXRs), sterol-activated nuclear receptors that regulate the expression of genes involved in cholesterol homeostasis and that have been causally linked to the pathogenesis of atherosclerosis. We identify the lncRNA MeXis as an amplifier of LXR-dependent transcription of the gene Abca1, which is critical for regulation of cholesterol efflux. Mice lacking the MeXis gene show reduced Abca1 expression in a tissue-selective manner. Furthermore, loss of MeXis in mouse bone marrow cells alters chromosome architecture at the Abca1 locus, impairs cellular responses to cholesterol overload, and accelerates the development of atherosclerosis. Mechanistic studies reveal that MeXis interacts with and guides promoter binding of the transcriptional coactivator DDX17. The identification of MeXis as a lncRNA modulator of LXR-dependent gene expression expands understanding of the mechanisms underlying cell type-selective actions of nuclear receptors in physiology and disease.
The accumulation of excess cholesterol by macrophages within the arterial wall is a pivotal step in the pathogenesis of atherosclerosis. The ability of macrophages to integrate metabolic and immune signaling in response to environmental cues and lipid excess is therefore an important determinant of disease susceptibility [1] [2] [3] . LXRs are ligand-dependent transcription factors that regulate expression of genes involved in macrophage responses to cholesterol and also modulate inflammatory signaling 4, 5 . Activation of LXRs promotes reverse cholesterol transport through induction of a cadre of genes, including Abca1, which encodes the plasma membrane transporter ABCA1. This ATP-dependent transporter is critical for high-density lipoprotein (HDL) generation, and its function is compromised in Tangier disease, a syndrome characterized by both HDL deficiency and accelerated atherosclerosis 6, 7 .
LncRNAs have been shown to function through diverse mechanisms, including exerting direct transcriptional effects in response to environmental cues 8 . A number of lncRNAs have been shown to regulate the expression of neighboring genes; however, the mechanisms through which noncoding gene activation serves local regulatory functions remain to be fully clarified 9, 10 . Although a number of lncRNAs have been shown to have sequence-specific features, recent work highlights the strong contribution of neighboring promoter activity, including the processes of transcriptional initiation and splicing, on gene expression 11 . In this work, we characterize an LXRresponsive lncRNA that affects transcriptional pathways linked to macrophage cholesterol efflux and atherosclerosis. Our results suggest that cell type-selective action of lncRNAs contribute to the temporal and spatial gene activation patterns of nuclear receptors.
RESULTS

Regulation of macrophage lncRNAs in response to cholesterol loading
LXRs influence the expression of a large repertoire of genes linked to lipid metabolism in a context-specific fashion. We noted that the gene encoding the critical cholesterol efflux mediator ABCA1 was much more highly induced by synthetic LXR in macrophages than in other cell types, such as hepatocytes and adipocytes ( Supplementary  Fig. 1a ). To gain insight into the basis for this cell type-selective LXR response, we performed genome-wide transcriptional profiling on mouse peritoneal macrophages treated with or without the synthetic LXR agonist GW3965. The expression of canonical protein-coding LXR target genes was robustly induced by LXR agonist treatment, as expected ( Supplementary Fig. 1b ). In accordance with the established roles for LXR in metabolism, the network of ontology terms for genes with GW3965-regulated expression showed robust enrichment for lipid regulatory processes and macrophage-specific pathways (Supplementary Fig. 1c ). Interestingly, we also observed that LXR activation induced a limited number of lncRNAs ( Supplementary  Fig. 1d and Supplementary Table 1 ). Several of these lncRNAs are located in genomic regions neighboring protein-coding genes with established roles in mediating LXR effects on metabolism. Gene ontology analysis of protein-coding genes that were nearest to these lncRNAs showed enrichment for cholesterol metabolic processes, consistent with the idea that a subset of these lncRNAs may modulate the activity of adjacent protein-coding genes ( Supplementary Table 2 ).
Among the list of regulated lncRNAs in Supplementary Table 2 , a predicted transcript annotated as AI427809 was one of the most robustly induced hits that also showed evidence for LXR binding to its gene regulatory regions in LXR chromatin immunoprecipitation and sequencing (ChIP-seq) studies 12 . We named this transcript MeXis (macrophage-expressed LXR-induced sequence). Notably, the MeXis gene is located in close proximity to the established LXR target genes Abca1 and 4930412L05Rik (LeXis) 13 (Fig. 1a) . Analysis of chromatin signatures from the Encyclopedia of DNA Elements (ENCODE) indicated that MeXis and Abca1 are distinct genes with separate promoters (Fig. 1a) 14, 15 . 5′ and 3′ rapid amplification of Fig. 2 ). RNA copy number analysis showed that MeXis was highly expressed in mouse macrophages ( Supplementary  Fig. 3a) , and real-time PCR analysis showed that MeXis and Abca1 expression was induced by LXR (GW3965) and retinoid X receptor (RXR; LG268) agonists in primary macrophages in an LXR-dependent manner ( Fig. 1b) 
Abca1 Abca1 low-density lipoprotein (LDL; Fig. 1c ). In addition, the oxysterol agonist of LXR induced MeXis expression in macrophages ( Supplementary  Fig. 3b ). Intriguingly, MeXis showed a distinct pattern of LXRdependent regulation as compared to the lncRNA LeXis, which is expressed in liver but not macrophages ( Fig. 1d ) 13 . MeXis was also expressed in adipose tissue ( Supplementary Fig. 3c ).
MeXis is an LXR-responsive lncRNA that influences Abca1 expression
We identified an LXR-response element (LXRE) within the MeXis promoter region that was bound by LXRs in ChIP-seq analysis ( Fig. 1e) .
In contrast to most of the LXR target genes, which are responsive to both LXRβ and LXRα, the MeXis promoter was bound by LXRβ but not LXRα. Consistent with this result, MeXis expression was induced by LXR activation in wild-type (WT) Nr1h3 +/+ (Lxrα +/+ ) and Lxrα −/− but not Nr1h2 −/− (Lxrβ −/− ) peritoneal macrophages, whereas Abca1 expression was responsive to both LXRs ( Fig. 1f and Supplementary Fig. 3d ).
To further explore isoform-specific regulation of MeXis, we treated immortalized LXR double-knockout (DKO) bone marrow-derived macrophages (BMDMs), as well as LXR-DKO BMDMs stably expressing LXRα, with GW3965. Abca1 was induced with LXR activation in LXRα-expressing BMDMs but not in DKO controls, whereas MeXis was not induced in either cell type ( Supplementary Fig. 3e ). These data further suggest that MeXis is an LXRβ-selective target gene. Computational scores that distinguish protein-coding from noncoding RNAs predicted a low coding potential for the MeXis transcript ( Fig. 1g) . Although the MeXis transcript does contain a number of short potential open-reading frames, we found no evidence of translation and production of a protein product from MeXis using a coupled in vitro transcription-translation assay ( Supplementary Table 3 and Supplementary Fig. 4a ). Single-molecule RNA fluorescence in situ hybridization (FISH) in immortalized BMDMs from mice confirmed the nuclear localization of MeXis ( Supplementary Fig. 4b ). MeXis was predominantly located in the insoluble nuclear pellet enriched for chromatin, whereas the protein-coding 36b4 mRNA was predominantly present in cytoplasm ( Supplementary Fig. 4c ). Even when exogenously expressed at elevated levels, MeXis was predominantly nuclear (Supplementary Fig. 4d ). This localization strongly suggests that MeXis most likely acts as a nuclear RNA, rather than being translated into a short protein in the cytoplasm.
As some lncRNAs have been shown to regulate the expression of adjacent genes 16, 17 , we hypothesized that loss of MeXis may impact the expression of Abca1. In support of this idea, siRNA-mediated knockdown of either MeXis or RXRα in mouse peritoneal macrophages decreased Abca1 transcript levels ( Fig. 2a ). An antisense oligonucleotide (ASO) targeting MeXis also reduced levels of Abca1 expression ( Supplementary Fig. 4e ). Reciprocally, stable overexpression of MeXis in macrophages enhanced Abca1 expression and cholesterol efflux capacity to apolipoprotein A-1 (ApoA-I) acceptors (Fig. 2b,c and Supplementary Fig. 4f ).
MeXis deficiency affects Abca1 expression, cholesterol efflux, and atherogenesis
To better decipher the contributions of MeXis to macrophage metabolism, we generated MeXis-knockout mice (Supplementary Fig. 5a ). We used a strategy in which flippase (FLP) excised the targeting cassette following homologous recombination such that no extraneous promoter sequences were left behind after recombination. Consistent with the results from our siRNA studies, MeXis −/− peritoneal macrophages showed decreased Abca1 transcript levels ( Fig. 2d) . Notably, in Western-diet-fed mice, Abca1 mRNA expression was differentially altered across tissues in MeXis −/− mice as compared to WT mice ( Fig. 2d) . For example, liver Abca1 was not significantly different between groups, whereas heart and kidney Abca1 expression was lower in MeXis −/− mice than in WT mice ( Fig. 2d) . We also confirmed that ABCA1 protein levels were reduced in MeXis −/− macrophages relative to WT macrophages ( Fig. 2e) . These results suggest that MeXis augments Abca1 expression in a context-specific manner. We observed minimal changes in the expression of other LXR target genes in response to MeXis overexpression, knockdown, or knockout ( Supplementary Fig. 5b-d ), suggesting that MeXis does not regulate all LXR target genes equivalently. Unbiased transcriptomic analysis of WT and MeXis −/− primary peritoneal macrophages showed enrichment for lipid metabolic pathways and inflammatory signaling ( Supplementary Table 4 ). Consistent with the alteration in Abca1 expression in MeXis −/− macrophages, we observed a decrease in ApoA-I-dependent efflux capacity in peritoneal macrophages from MeXis −/− mice as compared to WT mice ( Fig. 2f and Supplementary  Fig. 4g ). By contrast, loss of MeXis in macrophages was not associated with a change in cholesterol uptake ( Supplementary Fig. 4h ). Furthermore, as compared to WT macrophages, MeXis −/− peritoneal macrophages showed elevated cholesterol content in vivo in Western-diet-fed mice (Fig. 2g) . Additionally, morphological 'foam cell' formation, as assessed by Oil red O staining, was more enhanced in MeXis −/− peritoneal macrophages ( Fig. 2h and Supplementary  Fig. 4i ). In accordance with the idea that MeXis primarily affects macrophage responses, there were no differences in serum cholesterol or triglyceride levels between MeXis −/− and WT mice, either when fed a chow or Western diet ( Supplementary Fig. 6 ). Taken together, these results suggest that MeXis is required for maximal Abca1 expression in the face of macrophage cholesterol loading.
To further explore the ability of MeXis to act as a regulatory RNA and to confirm its ability to modulate Abca1 expression in vivo, we expressed MeXis in mouse liver using an adenoviral vector. Notably, we observed an increase in serum cholesterol levels-a hallmark feature of enhanced hepatic ABCA1 expression-in mice ectopically expressing MeXis in liver ( Fig. 2i) . We also confirmed that MeXis expression in liver induced Abca1 mRNA expression without affecting that of other LXR target genes ( Fig. 2j ). ABCA1 protein levels were correspondingly increased through MeXis expression ( Fig. 2k) .
Cholesterol efflux capacity is an important determinant of atherosclerotic plaque development and progression. To examine the impact of MeXis on atherosclerosis, we reconstituted the bone marrow of irradiated Ldlr −/− mice with WT or MeXis −/− hematopoietic cells ( Fig. 3a) . Real-time PCR analysis of bone marrow from recipient mice collected at the time of euthanization confirmed engraftment ( Supplementary Fig. 7a ). We found reduced Abca1 expression and enhanced inflammatory gene expression in the bone marrow of mice transplanted with MeXis −/− bone marrow (Supplementary Fig. 7a ). En face analysis of the atherosclerotic plaque area after 17 weeks of Western diet feeding showed markedly increased atherosclerotic burden in mice transplanted with MeXis −/− bone marrow as compared to WT bone marrow ( Fig. 3a,b ). No differences in plasma cholesterol or triglyceride levels were observed between the two groups ( Supplementary Fig. 7b ). Consistent results were obtained when we assessed atherosclerosis by quantification of Oil red O-stained aortic root sections ( Fig. 3c,d) . Histological analysis showed larger lesions, as well as increased staining for the macrophage-specific marker CD68, in mice transplanted with MeXis −/− bone marrow than in those transplanted with WT bone marrow ( Fig. 3e and Supplementary Fig. 7c ). Laser-capture microdissection of CD68-positive cells revealed Chr. 4:
Normalized expression
Normalized expression decreased expression of Abca1 and MeXis in macrophages within atherosclerotic lesions from mice transplanted with MeXis −/− bone marrow relative to those transplanted with WT bone marrow ( Fig. 3f,g) . Taken together, these results demonstrate that macrophage MeXis expression is a determinant of susceptibility to atherosclerosis in mice.
MeXis interacts with DDX17 and modulates Abca1 transcription
Enhancer RNA (eRNA; short noncoding RNAs transcribed from enhancer elements) expression can serve as a surrogate marker for enhancer site activity and transcriptional activation 18 . Enhancer elements surrounding Abca1 in macrophages have been defined previously ( Supplementary Fig. 8 ) 19 . Interestingly, MeXis −/− macrophages showed decreased eRNA expression from Abca1 enhancers in response to LXR activation as compared to WT cells (Fig. 4a) . To assess whether MeXis can affect transcription of the Abca1 gene in trans, we crossed mice with loxP-flanked Abca1 (Abca1 flox/flox ) with heterozygous MeXis +/− mice. This strategy enabled us to measure the effects of MeXis deficiency specifically on the Abca1 transcript that is trans to the mutant MeXis allele. We found that a reduction in MeXis expression reduced Abca1 expression in trans ( Fig. 4b and Supplementary Fig. 9a) .
These observations led us to hypothesize that MeXis may influence chromatin dynamics at the Abca1 locus, thereby modulating its transcription. In accordance with this idea, an assay for transposaseaccessible chromatin using sequencing (ATAC-seq) performed on peritoneal macrophages showed blunted accessibility at multiple sites within the Abca1 gene locus in the setting of MeXis deficiency (Fig. 4c) . Quantification of accessible sites neighboring the Abca1 promoter revealed decreased accessibility in MeXis −/− macrophages. By contrast, we found no difference in accessibility at the Tlr4 locus ( Fig. 4d) , indicating selectivity of the effect of MeXis deficiency for certain chromatin regions. Genome-wide normalization revealed that the LXR target gene activation signature was largely preserved in MeXis-deficient macrophages; however, multiple sites within the Abca1 locus showed differential accessibility between WT and MeXis −/− macrophages ( Fig. 4e and Supplementary Fig. 9b) . By contrast, the accessibility was substantially altered for very few sites at other LXR target gene loci (Supplementary Fig. 9c ). Unbiased genome-wide analysis of differentially accessible chromatin sites between WT and MeXis −/− macrophages showed enrichment for lipid transport and related processes (Supplementary Fig. 9d) .
To further investigate the mechanism of MeXis action, we used an unbiased lncRNA-chromatin affinity capture technique 20 to pull down MeXis from macrophage extracts and to identify interacting proteins (Supplementary Fig. 10a) . Analysis of the MeXis interactome by mass spectrometry identified DDX17, an established nuclear receptor coactivator 21, 22 , as a potential interacting partner (Supplementary Fig. 10b ). We confirmed a robust interaction between MeXis and DDX17 in RNA immunoprecipitation studies in mouse macrophages, either with or without the use of a cross-linking agent (Fig. 5a) . The prior characterization of DDX17 as a transcriptional coactivator led us to hypothesize that DDX17 may perform this function at the Abca1 locus. In line with this idea, ChIP-PCR analysis revealed that DDX17 was enriched at LXR-binding sites in Abca1 enhancer regions in macrophages (Fig. 5b) . Moreover, DDX17 binding was substantially reduced as a consequence of MeXis deletion (Fig. 5b) . Interestingly, the pattern of LXR binding was also altered as a consequence of loss of MeXis, with reduced occupancy at the Abca1 promoter but enhanced binding at an intronic site (Fig. 5b) . These results suggest that MeXis facilitates the coactivating actions of DDX17 to enhance LXR-mediated Abca1 expression. To definitively determine whether MeXis is recruited to the Abca1 gene locus, we used chromatin isolation via RNA purification (ChIRP)-qPCR. Through this technique, we found that MeXis bound to a number of sites at Abca1 that show differential accessibility between MeXis −/− and WT macrophages (Fig. 5c ) To further define the importance of DDX17 in Abca1 regulation, we generated DDX17-deficient immortalized BMDMs using CRISPR-Cas editing (Supplementary Fig. 10c ). Deletion of DDX17 using two different excision strategies reduced Abca1 levels at baseline and in response to LXR activation (Fig. 5d,e) . These results strongly suggest that DDX17 is required for maximal Abca1 expression in macrophages. To analyze the epistatic relationship between DDX17 and MeXis, we generated Ddx17-MeXis DKO macrophages using CRISPR-Cas. Deletion of MeXis in the setting of Ddx17 deficiency failed to further reduce Abca1 transcript or protein levels as compared to single knockout of Ddx17 (Fig. 5f,g) . Taken together, these results demonstrate that DDX17 contributes to MeXis-dependent regulation of Abca1.
Finally, we assessed whether the LXR-MeXis-Abca1 pathway is operational in human cells. Genome batch conversion between human and mouse genome builds revealed that the genomic region surrounding the MeXis-Abca1 locus showed a degree of conservation between species (Supplementary Fig. 11) . A noncoding human RNA transcript in this region, identified as TCONS00016111, showed some sequence conservation with MeXis ( Fig. 6a and Supplementary  Fig. 11) . Intriguingly, TCONS00016111 expression was induced in response to LXR activation in human THP-1 macrophages (Fig. 6b) . Moreover, ASOs targeting TCONS00016111 reduced ABCA1 transcript levels and ApoA-I-specific cholesterol efflux (Fig. 6c,d) . Furthermore, lentiviral transduction of MeXis into MeXis −/− or THP-1 WT human macrophages increased ABCA1 expression ( Fig. 6e,f) .
Finally, genome-wide association study (GWAS) data from the CARDIoGRAMplus consortium 23 identified a moderately significant association between a SNP overlapping the TCONS00016111 transcript and human coronary artery disease (P = 4.78 × 10 −6 , chi-squared test; Fig. 6g) . These results support the notion that an LXR-lncRNA-Abca1 axis is operational in humans and may have relevance in human disease.
DISCUSSION
Previous work has identified important roles for eRNAs in regulating gene expression programs 24 . Our study expands the repertoire of noncoding RNA-mediated gene activation by showing that a lncRNA can help specify nuclear receptor regulatory circuits. Our results suggest that induction of MeXis expression in response to activation of LXRs augments Abca1 expression and macrophage cholesterol efflux in a context-specific manner. It seems likely that MeXis may contribute to cell type-specific regulation of Abca1 expression by LXRs. Our work, however, does not exclude the possibility that MeXis may have targets other than Abca1.
Our findings are consistent with previous reports stating that intergenic lncRNAs and their genomically adjacent protein-coding genes tend to exhibit similar spatiotemporal expression profiles 25, 26 . Recent work suggests that at least some of the local effects of lncRNAs are the results of promoter activity and the act of transcription rather than lncRNA-specific features 11 . Although our results do not exclude the possibility that cis-regulatory elements at the MeXis locus exert an influence on Abca1 transcription, our data support the idea that transcript-dependent actions also contribute to Abca1 regulation.
This study also reveals an unexpected role for a lncRNA in cardiovascular disease. Control of macrophage gene expression by the LXR pathway is causally linked to the pathogenesis of atherosclerosis. Identification of MeXis fills a gap in the understanding of pathways that control cellular responses to cholesterol overload and atherosclerosis. It is tempting to speculate that targeting the LXR-MeXis-Abca1 axis may enhance macrophage reverse cholesterol transport to treat or prevent atherosclerotic disease while bypassing undesirable side effects of LXR activation in other tissues.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Reagents, plasmids, and gene expression. GW3965 was synthesized as previously described 27 .
LG268 was obtained from Ligand Pharmaceuticals. Oxysterols were purchased from Sigma and used as described 28 . Simvastatin sodium salt was from Calbiochem. Ligands were dissolved in dimethyl sulfoxide before use in cell culture. MeXis was amplified from RNA purified from GW3695-treated primary mouse peritoneal macrophages using KOD polymerase (Millipore), with forward 5′-GTCTGAAAAGGAAGTTGAAGAAGA-3′ and reverse 5′-AAGGAATCTAGTAAATTTTAATACTAA-3′ primers. Primers were designed to provide flanking attB sequences and a SacI site at the immediate 3′ end. Details of oligonucleotide sequences are in Supplementary  Figure 12 . The fragments were then cloned into pDONR221 using the Gateway system, and the minimal SV40 polyadenylation sequence was inserted at the SacI site. ON-Targetplus siRNAs (catalog number R-050345) were used with Dharmafect 4 reagent per the manufacturer's recommendations for knockdown studies (Dharmacon). For gene expression analysis, RNA was isolated using TRIzol reagent (Invitrogen) and analyzed through real-time PCR using an Applied Biosystems 7900HT sequence detector or Applied Biosystems Quant Studio 6 Flex. Results are normalized to 36B4 or cyclophilin. The following antibodies were used for immunohistochemistry: CD68 (MCA1957GA, AbD; 1:400) with secondary antibody biotin-SP-conjugated AffiniPure goat anti-rat IgG (H+L) (Jackson Laboratories). Details of antibodies and full-length blots are provided in Supplementary Figures 13 and 14 . In brief, for immunoblot analysis, antibodies against the following proteins were used: ABCA1 (Novus; 1:1,000) and actin (Sigma; 1:10,000). For ChIP analysis, we used the LXR antibody previously described 29 ; DDX17 antibody was generated by D. Black, UCLA 30 . plentiCRISPR v2 was used for lentivirus production; the guide RNA was inserted into BsmB1-digested plasmid, and the plasmid was ligated with T4 DNA ligase. Guide insertions were verified via sequencing. For lentiviral overexpression studies, MeXis was cloned into the pSLIK-Zeo vector system 31 , which was modified for lncRNA expression by replacement of the sequence between the NcoI and MfeI sites in the pEN_TT entry vector with a minimal SV40 polyadenylation signal. The MeXis sequence was inserted into the NcoI site immediately upstream of the polyadenylation signal. Lentiviruses were packaged and purified as described 32 . For retroviral and adenoviral expression, the MeXis sequence was transferred from the pEN-TTpA entry vector to pBABE and pAd/CMV/V5-DEST, respectively, using the Gateway cloning system (Invitrogen Life Technologies).
Mice and diets.
Mice were housed in a temperature-controlled room under a 12-h light-12-h dark cycle and under pathogen-free conditions. Experiments used 12-week-old male mice unless otherwise specified. Age-matched male Ldlr −/− mice on the C57BL/6 background were purchased from Jackson Laboratories (catalog number 2207). Mice lacking LXRá and/or LXRâ were originally provided by D. Mangelsdorf, University of Texas Southwestern Medical Center 33 and were backcrossed to the C57BL/6 background for more than ten generations. MeXis global knockout mice on a C57BL/6 background were generated at the University of California Davis Knockout Mouse Project (KOMP) using the strategy outlined in Supplementary Figure 5 . Abca1 flox/flox mice on a C57BL/6 background were obtained from J. Parks, Wake Forest University 34 . Mice were fed a chow diet except when indicated that mice were placed on a Western diet (21% fat, 0.21% cholesterol; D12079B; Research Diets, Inc.). We measured cholesterol and triglycerides as previously described 13 . At the time of euthanization, tissues and blood were collected by cardiac puncture and immediately frozen in liquid nitrogen and stored at −80 °C. For adenoviral infections, age-matched male mice were injected with 2.0 × 10 9 PFU by tail-vein injection and were euthanized 6 d later following a 6-h fast. Tissue was processed for isolation of RNA as described above. All mouse experiments were approved by the University of California Los Angeles Institutional Animal Care and Research Advisory Committee and performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Cell culture. Primary peritoneal macrophages were isolated 4 d after thioglycollate injection and prepared as described 27 . Mouse primary hepatocytes were isolated as previously described and cultured in William's E medium with 5% FBS 27 . Peritoneal cells were incubated in 0.5-10% FBS in DMEM, with or without 5 µM simvastatin and 100 µM mevalonic acid (EMD Biosciences). Five to eight hours later, cells were pretreated with DMSO or an appropriate ligand overnight. The in vitro translation assay was performed using the TnT Coupled Transcription/Translation System (PROMEGA) according to the manufacturer's protocol. THP-1 cells from ATCC were treated with custom siRNA from Dharmacon (50 nM) and harvested 36 h later. Modified gapmer ASOs were obtained from IDT and used with Dharmafect 4 or Attractene transection reagent at a final concentration of 50 nM. THP-1 cells were differentiated with phorbol 12-myristate 13-acetate (PMA) at 10 ng/ml followed by GW3965 treatment. Immortalization of BMDMs to generate stable cell lines was performed as previously described 34 . These stable cell lines were obtained via puromycin selection of lentivirus-treated cells starting from a single clonal population. Gene expression or western blot results are shown for a pool of selected cells unless otherwise noted. All cell lines were tested for mycoplasma contamination. Subcellular RNA fractions were obtained according to the protocol of Bhatt et al. 31 and as we previously described 13, 35 .
Cholesterol efflux and uptake. Assays were performed as previously described 27 . Briefly, peritoneal macrophages from WT or MeXis −/− mice were labeled with [ 3 H]cholesterol (1.0 µCi/ml) (Perkin Elmer) in the presence of acyl-CoA:cholesterol O-acyltransferase inhibitor (2 µg/ml), followed by treatment with DMSO or LXR (1 µM GW3965). After equilibration of the cholesterol pools and washing, cells were incubated in DMEM containing 0.2% BSA in the absence or presence of ApoA-I (Meridian Life Sciences) (15 µg/ml) or HDL purchased from Lee Biosolutions (catalog number 361-10-0.01) (50 µg/ml) for 6 h. The data are presented as percent ApoA-I-or HDLspecific efflux. For uptake assays, resident mouse peritoneal macrophages were obtained from age-matched WT and MeXis −/− mice. Peritoneal macrophages were suspended in starvation medium (1% Lipoprotein Deficient Serum (LPDS), simvastatin, mevalonic acid) and incubated at 37 °C for 16 h. Cells were then treated with DiI-acetyl-LDL (Invitrogen) at concentrations of 0 µg/ml (control), 50 µg/ml, and 100 µg/ml and incubated at 37 °C for an additional 4 h. After the 4-h incubation period, cells were washed three times with PBS containing bovine serum albumin (2 mg/ml), harvested, and lysed in RIPA buffer. To measure the uptake of DiI-acetyl-LDL by peritoneal macrophages, cell lysates were analyzed for fluorescence using a Clario Star plate reader with an excitation of 554 nm and an emission of 571 nm. Values for fluorescent intensity were normalized to total protein concentration and are displayed relative to the untreated group.
Atherosclerosis analysis.
Immunohistochemistry of sections and preparation and staining of frozen and paraffin-embedded sections from aortas were performed as described previously 36 . Atherosclerosis in the aortic roots and the descending aortas (en face) was quantified by computer-assisted image analysis as described 37 . Atherosclerotic lesions at the aortic valve were analyzed as described 27 . Laser capture microdissection was used as previously outlined 38 , except that a LMD7000 Laser Microdissection System (Leica) was used at the UCLA Advanced Microscope CNSI core lab. The Arcturus PicoPure RNA Isolation Kit (Applied Biosystems) was used for RNA processing and amplification.
RACE.
The 5′ and 3′ ends of the MeXis transcript were defined using mouse peritoneal macrophage RNA and the FirstChoice RLM-RACE kit (Ambion) according to the manufacturer's protocol with modifications. Briefly, for 5′ RACE, degraded mRNA 5′ ends were dephosphorylated with calf intestinal phosphotase (CIP) and full-length mRNA was uncapped with tobacco acid pyrophosphotase (TAP). Following 5′ RACE adaptor ligation, reverse transcription was performed using the SuperScript III First-Strand Synthesis system (Invitrogen) and MeXis-specific primers. For 3′ RACE, RNA was reverse transcribed using the SuperScript III First-Strand Synthesis system (Invitrogen) and adaptor-linked oligo(dT). The resulting cDNA was amplified by nested PCR across a 55-65 °C melting temperature gradient using KOD polymerase (Millipore), with the inner primers containing attB sequences. Aliquots of reactions were inspected on 1% agarose gels for product size and abundance. Products of selected PCR reactions were purified using the NucleoSpin Gel and PCR Cleanup kit (Clontech) and were inserted into pDONR221 by Gateway cloning procedures. Cloned fragments were sequenced and then aligned to the mouse genome with the BLAST analysis tool. RNA fractionation assays were done as previously described 13 .
RNA sequencing. RNA sequencing libraries were constructed with TruSeq RNA Sample Prep Kits (Illumina) using RNA isolated from peritoneal macrophages treated with or without GW3965. Samples were indexed with adaptors and submitted for paired-end 2 × 100-bp sequencing using an Illumina HiSeq 2000 instrument. RNA-seq reads were aligned with TopHat v2.0.2 to the mouse genome, version mm9 (ref. 39) . Transcripts were assessed and quantities were determined using Cufflinks v2.0.2 with a GTF file based on Ensembl mouse NCBI37. Comparisons of expression levels were made using fragments per kilobase of transcript per million mapped reads (FPKM) values with Cuffdiff from the Cufflinks package 40 . In order to analyze lncRNA expression in more depth, we built a comprehensive, nonredundant mouse gene database by merging the Gencode and Noncode annotations. Reads were aligned to the mouse genome (GRC38/mm10 assembly) using STAR 41 . Gene-level count summaries were estimated with HTSeq. We employed a comprehensive, nonredundant mm10 genome annotation that incorporates protein-coding and lncRNA genes from Gencode and lncRNA annotations from Noncode v4 (ref. 42) . Coding potential scores for each transcript in the merged annotation were estimated with CPAT 43 . In addition, we used CNCI as another method to classify the coding potential of sequences of interest 44 . Gene-level expression estimates in units of FPKM were computed in house as above. For downstream analysis, the following entries were masked: (1) genes with no counts, (2) genes with low (<50 bp) nucleotide sequence uniqueness, and (3) Gencode biotypes other than protein coding or lncRNA. The final genome annotation we employed for downstream analyses comprised 50,608 genes (21,098 protein coding; 29,510 lncRNA). Expression fold changes after GW3965 treatment were estimated from FPKM ratios. Enrichment analyses on the set of upregulated coding and noncoding genes included pathway analyses with MetaScape and cis-regulatory region enrichment analyses with default parameters in GREAT 45 .
Lipid analysis. Cellular lipid content was obtained using a Folch extraction. Briefly, chloroform extracts were dried under nitrogen and solubilized in water. Tissue and serum cholesterol and triglyceride content was determined using a commercially available enzymatic kit (Wako). Mice were fasted for at least 6 h before blood collection and euthanization.
ChIP. ChIP studies were performed as described elsewhere 13 . Briefly, primary mouse peritoneal macrophages (approximately 40 million per sample) were cross-linked using a final formaldehyde concentration of 1% at room temperature for 10 min. The reaction was quenched with the addition of glycine. Sonicated chromatin isolated with lysis buffer (50 mM HEPES-KOH, pH 7.5; 140 mM NaCl; 1 mM EDTA; 10% glycerol; 0.5% NP-40; 0.25% Triton X-100) was incubated overnight at 4 °C with control IgG or 2.5 µg/ml of lysate of anti-LXR (previously generated by JaKobsson et al. 29 from Karolinska Institute) or anti-DDX17 (gift of D. Black, UCLA) antibody. Protein A Dynabeads (Invitrogen) were added for 4 h. Washing, reverse cross-linking, and sample elution were performed as previously outlined 13 . ChIP-seq for LXR isoforms was done using Flag-tagged LXRá or LXRâ in immortalized BMDM cell lines 34 . Macrophages (12 × 10 6 ) were cross-linked using a double-fixation protocol with 2 mM disuccinimidyl glutarate for 30 min and 1% methanol-free ultrapure formaldehyde for 10 min before quenching with 2 M glycine. Cells were lysed with RIPA buffer and, after chromatin shearing by sonication using a Bioruptor (Diagenode) apparatus, incubated overnight with protein G magnetic Dynabeads (Invitrogen) coupled with 3 µg of either anti-Flag M2 (Sigma, catalog number F3165) or anti-H3K27ac (Abcam, catalog number ab4729) antibodies. Immunoprecipitated DNA was purified using a Qiagen purification kit (Qiagen, catalog number 28144). For high-throughput sequencing, a minimum of 10 ng of DNA was obtained by pooling DNA from ten independent ChIP preparations (for Flag-LXR sequencing) or six different ChIP preparations (for H3K27ac sequencing). DNA was then used for library preparation and subsequent Illumina HiSeq sequencing by the Centre de Regulació Genomica (CRG, Barcelona, Spain) genome facility. Fluorescent RNA FISH. Custom design RNAscope probes against MeXis were prepared and obtained from Advanced Cell Diagnostics (catalog number 495011). MeXis was visualized in immortalized mouse BMDMs using an RNAscope assay and the Multiplex Fluorescent Reagent Kit V2, following the manufacturer's recommended protocol with use of a HybEZ oven (Advanced Cell Diagnostics); however, we used a protease dilution of 1:5 instead of 1:30.
RNA immunoprecipitation. We followed the protocol outlined by Tsai and colleagues 46 . Briefly, cellular extracts from native or cross-linked (1% formaldehyde) primary peritoneal macrophages were treated with DNase I followed by incubation with DDX17 antibody or IgG control overnight. Complexes were captured using Dynabead Protein G (Life Technologies), and RNA was eluted using the RNeasy micro kit (Qiagen).
Microarrays. cDNA microarray analysis was performed for primary peritoneal macrophages treated with GW3695. Transcriptional profiling was performed at the University of California, Los Angeles, TCGB core facility using the Agilent SurePrint G3 Gene Expression array. Data were analyzed using GeneSpring software (Agilent Technologies) and DAVID Functional Analysis Tools 47 .
ChIRP. ChIRP was performed as described 20 with a few modifications. First, cross-linking of RAW264.7 cells from ATCC treated with GW3965 was done using 3% formaldehyde. Second, we used a longer probe design algorithm (~50 bp instead of the recommended 20 bp) that optimized the signal-to-noise ratio and MeXis retrieval, as determined using pilot experiments comparing shorter and longer probe sets performed with RNase and DNase controls. For ChIRP by mass spectrometry (ChIRP-MS), the final protein elution was done in a solution of 50 mM triethyl ammonium bicarbonate, 12 mM sodium lauryl sarcosine, and 0.5% sodium deoxycholate.
ATAC-seq.
Peritoneal macrophages were isolated and treated for 3 h with or without GW3965. Using four replicates per condition, libraries were prepared using the Nextera Tn5 Transposase kit (Illumina) as described 48 with slight modifications. Libraries were single-end sequenced (50 bp) on an Illumina HiSeq 2000 instrument. Reads were mapped to the mouse genome (NCBI37/ mm9) using Bowtie2 and were removed from the subsequent analysis if they were duplicated, mapped to the mitochondrial genome, or aligned to unmapped contiguous sequences. Peak calling was performed using MACS2 with parameters callpeak --nomodel -g mm --keep-dup all -q 0.01 --llocal 10000. Overlapping peaks were merged together and used as probes for quantifying reads. The reads were converted to reads per million (RPKM) by dividing by the total number of reads within a peak divided by the peak length per million mapped reads.
The average RPKM from four replicates was used to quantify the accessibility across all called peaks. Significance was determined by the DESeq2 package in R Bioconductor 49 . P values were adjusted using the Benjamini-Hochberg procedure for multiple-hypothesis testing 50 .
Statistical analysis.
An unpaired Student's t-test was used to determine statistical significance, defined at P < 0.05. For multiple-group experiments, ANOVA was used, followed by multiple-group analysis. Unless otherwise noted, error bars represent s.d. Except as noted in figure legends, experiments were independently performed twice. Sample size was based on statistical analysis of variance and prior experience with similar in vivo studies.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary. Data availability. The source data used in the manuscript can be accessed using the following accession numbers: GSE98910 (RNA-seq), GSE97207 (ATAC-seq), GSE104027 (ChIP-seq), and GSE107977 (microarray). The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Most study analysis was done using excel or prism. Bioinformatic analysis is discussed in detail in methods. Specific software used included Genespring, DAVID, NONCODE, CNCI.
For all studies, we encourage code deposition in a community repository (e.g. GitHub). Authors must make computer code available to editors and reviewers upon request. The Nature Methods guidance for providing algorithms and software for publication may be useful for any submission.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No restrictions.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
See supplemental data for all antibody details. We used established tagged antibodies which are described in methods and chip. These antibodies were used in previous publications and purchased from well-known vendors. The only exception is the DDX17 antibody which was homemade and a gift from Dr. Douglas Black. The KO results blot size and bands validate the DDX17 antibody. c. Report whether the cell lines were tested for mycoplasma contamination.
We routinely test cells for myocoplasma. All cells used in the study tested negative.
d. If any of the cell lines used in the paper are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
